The ICMR-National Institute for Research in Reproductive Health, along with PGI Chandigarh and NIIH, conducted a comprehensive assessment and determined that point-of-care tests for sickle cell disease/trait among the high-risk population in India would be cost-effective if procured at Rs 100 per test or below.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2xOcPVq
via gqrds
No comments:
Post a Comment